---
pmid: '21741598'
title: A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
authors:
- Girardini JE
- Napoli M
- Piazza S
- Rustighi A
- Marotta C
- Radaelli E
- Capaci V
- Jordan L
- Quinlan P
- Thompson A
- Mano M
- Rosato A
- Crook T
- Scanziani E
- Means AR
- Lozano G
- Schneider C
- Del Sal G
journal: Cancer Cell
year: '2011'
full_text_available: false
doi: 10.1016/j.ccr.2011.06.004
---

# A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
**Authors:** Girardini JE, Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E, Capaci V, Jordan L, Quinlan P, Thompson A, Mano M, Rosato A, Crook T, Scanziani E, Means AR, Lozano G, Schneider C, Del Sal G
**Journal:** Cancer Cell (2011)
**DOI:** [10.1016/j.ccr.2011.06.004](https://doi.org/10.1016/j.ccr.2011.06.004)

## Abstract

1. Cancer Cell. 2011 Jul 12;20(1):79-91. doi: 10.1016/j.ccr.2011.06.004.

A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.

Girardini JE(1), Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E, Capaci 
V, Jordan L, Quinlan P, Thompson A, Mano M, Rosato A, Crook T, Scanziani E, 
Means AR, Lozano G, Schneider C, Del Sal G.

Author information:
(1)Laboratorio Nazionale CIB, Trieste, Italy.

TP53 missense mutations dramatically influence tumor progression, however, their 
mechanism of action is still poorly understood. Here we demonstrate the 
fundamental role of the prolyl isomerase Pin1 in mutant p53 oncogenic functions. 
Pin1 enhances tumorigenesis in a Li-Fraumeni mouse model and cooperates with 
mutant p53 in Ras-dependent transformation. In breast cancer cells, Pin1 
promotes mutant p53 dependent inhibition of the antimetastatic factor p63 and 
induction of a mutant p53 transcriptional program to increase aggressiveness. 
Furthermore, we identified a transcriptional signature associated with poor 
prognosis in breast cancer and, in a cohort of patients, Pin1 overexpression 
influenced the prognostic value of p53 mutation. These results define a 
Pin1/mutant p53 axis that conveys oncogenic signals to promote aggressiveness in 
human cancers.

Copyright Â© 2011 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.ccr.2011.06.004
PMID: 21741598 [Indexed for MEDLINE]
